MAPT and Alzheimer disease: This is consistent with various in vitro and in vivo models of AD, demonstrating that increased neuronal activity stimulates the release of the microtubule‐associated protein tau, which further enhances tau pathology [9, 10], as well as augmentation of Aβ depositions from presynaptic terminals [11].